<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02096640</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1136-31/2</org_study_id>
    <secondary_id>2013/1136-31/2LTS</secondary_id>
    <nct_id>NCT02096640</nct_id>
  </id_info>
  <brief_title>Postoperative Inflammation and Recovery After Tracheostomy</brief_title>
  <official_title>Randomized Controlled Trial on the Effect of Percutaneous Dilatation Tracheostomy Compared to Open Surgical Tracheostomy on Postoperative Inflammation, Pulmonary Function, Peri- and Postoperative Complications and Physical Mobilization.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sormland County Council, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sormland County Council, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to examine if there are differences in postoperative
      inflammation following percutaneous dilatation tracheostomy versus surgical tracheostomy in
      intensive care unit patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Are there differences between the two arms in plasma concentrations of inflammatory mediators
      (TNF-alfa, interleukin 1, 6, 10) at 24 hrs following the start of the surgical procedure? Are
      there differences between the two arms in the incidence of postoperative complications (i.e.
      bleeding, incidence of stomal infections, tracheal tube dislocation, airway compromisation),
      postoperative pulmonary infection (during the stay in the ICU) and pulmonary function (FEV1,
      dynamic complicance, oxygen demand, time to weaning off the ventilator: all measured daily
      during the ICU-stay), postoperative mobilization (time to mobilization to sitting, standing
      and walking, respectively)?
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in inflammation markers in plasma</measure>
    <time_frame>Preoperative and 24 hours after the start of surgery</time_frame>
    <description>Plasma samples will be taken preoperative and 24 hours after the start of tracheostomy. The levels of TNF-alpha, IL-6 and IL-10 will be measured.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>Until discharge from the ICU</time_frame>
    <description>All postoperative complications will be noted daily during the ICU-stay, i.e. bleeding, incidence of stomal infections, tracheal tube dislocation, airway compromisation.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physical function</measure>
    <time_frame>One week after tracheostomy</time_frame>
    <description>Notes 7 Days after tracheostomy on the time to mobilization to sitting, standing and walking, respectively.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Tracheostomy Complication</condition>
  <condition>Inflammation</condition>
  <condition>Post-operative Complications</condition>
  <arm_group>
    <arm_group_label>Percutaneous dilatation tracheostomy: Smiths Medical</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Type of surgical teqnique for tracheostomy: Percutaneous dilatation tracheostomy. The set for the tracheostomy is bought from Smiths Medical TM.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open surgery tracheostomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Type of surgical teqnique for tracheostomy: Open surgical tracheostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Type of surgical teqnique for tracheostomy</intervention_name>
    <arm_group_label>Percutaneous dilatation tracheostomy: Smiths Medical</arm_group_label>
    <arm_group_label>Open surgery tracheostomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Patients in whom a tracheostomy is indicated (i.e. anticipated need of
        mechanical ventilation for &gt;7 days or anticipated risk for complicated extubation, e.g.
        anatomical signs of a compromised airway, reduced level of consciousness. Adults over 18
        years. Participants who are suitable for both surgery techniques.

        Exclusion Criteria:

        Children under 18 years, pregnancy and participants with anatomical defects that exclude
        them from percutaneous dilatation tracheostomy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Castegren, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre for Clinical Research, Uppsala University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ulrika H Skoog, PTh</last_name>
    <phone>016-104570</phone>
    <email>ulrika.skoog@dll.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Markus Castegren, MD, PhD</last_name>
    <phone>016-105737</phone>
    <email>markus.castegren@dll.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intensivvårdsavdelningen på Mälarsjukhuset</name>
      <address>
        <city>Eskilstuna</city>
        <state>Sörmland</state>
        <zip>631 88</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ulrika H Skoog</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markus Castegren, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2014</study_first_submitted>
  <study_first_submitted_qc>March 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2014</study_first_posted>
  <last_update_submitted>March 23, 2014</last_update_submitted>
  <last_update_submitted_qc>March 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sormland County Council, Sweden</investigator_affiliation>
    <investigator_full_name>Markus Castegren</investigator_full_name>
    <investigator_title>Med. dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

